{"transactions":[{"id":890173,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:26:16.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027."}],"balance_after":247047,"source":{"system":"sec-edgar","filing":"0002064832-26-000051","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000051/form4.xml","form_type":"4"}},{"id":931452,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:13:32.000Z","date":"2026-01-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":36676,"price":0.3985,"value":14615.386,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on January 22, 2026, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on January 22, 2026 of $0.3985/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 52,387 shares from the January 22, 2026 vesting installment of the Reporting Person's January 22, 2024 RSU grant, (b) 5,010 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (c) 120,000 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-fourth (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":660042,"source":{"system":"sec-edgar","filing":"0001779092-26-000002","document":"form4-01262026_090129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000177909226000002/form4-01262026_090129.xml","form_type":"4"}},{"id":987744,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-11-26T21:07:19.000Z","date":"2025-11-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":2544,"price":0.4166,"value":1059.8304,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on November 24, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on November 24, 2025 of $0.4166/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 2,466 shares resulting from the November 24, 2025 vesting installment of the Reporting Person's February 24, 2023 RSU grant, and the remaining 5,010 shares will vest on February 24, 2026, (b) 89,063 shares subject to Reporting Person's January 22, 2024 RSU grant that will vest in successive equal quarterly installments through January 22, 2026 and (c) 120,000 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-fourth (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":696718,"source":{"system":"sec-edgar","filing":"0001779092-25-000007","document":"form4-11262025_091116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000177909225000007/form4-11262025_091116.xml","form_type":"4"}},{"id":1013990,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-24T21:00:09.000Z","date":"2025-10-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":45225,"price":0.66,"value":29848.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on October 22, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on October 22, 2025 of $0.66/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 43,837 shares resulting from the October 22, 2025 vesting installment of the Reporting Person's January 22, 2024 RSU grant, and the remaining 89,063 shares will vest in successive equal quarterly installments through January 22, 2026, (b) 10,020 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (c) 120,000 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-fourth (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":699262,"source":{"system":"sec-edgar","filing":"0001779092-25-000005","document":"form4-10242025_051005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000177909225000005/form4-10242025_051005.xml","form_type":"4"}},{"id":1056120,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-27T00:00:14.000Z","date":"2025-08-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1792,"price":0.5863,"value":1050.6496,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on August 24, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on August 22, 2025 of $0.5863/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 3,218 shares resulting from the August 24, 2025 vesting installment of the Reporting Person's February 24, 2023 RSU grant, and the remaining 10,020 shares will vest in successive equal quarterly installments through February 24, 2026, (b) 178,125 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest in successive equal quarterly installments through January 22, 2026 and (c) 120,000 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-quarter (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":744487,"source":{"system":"sec-edgar","filing":"0001415889-25-023074","document":"form4-08272025_120810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925023074/form4-08272025_120810.xml","form_type":"4"}},{"id":1082408,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-24T20:59:23.000Z","date":"2025-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":31866,"price":0.4798,"value":15289.3068,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on July 22, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on July 22, 2025 of $0.4798/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 57,197 shares resulting from the July 22, 2025 vesting installment of the Reporting Person's January 22, 2024 RSU grant, and the remaining 178,125 shares will vest in successive equal quarterly installments through January 22, 2026, (b) 15,030 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (c) 120,000 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-fourth (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":746279,"source":{"system":"sec-edgar","filing":"0001415889-25-020246","document":"form4-07242025_080720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925020246/form4-07242025_080720.xml","form_type":"4"}},{"id":1132470,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-28T20:05:08.000Z","date":"2025-05-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1792,"price":0.4733,"value":848.1536,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on May 24, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on May 23, 2025 of $0.4733/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 3,217 shares resulting from the May 24, 2025 vesting installment of the Reporting Person's February 24, 2023 RSU grant, and the remaining 15,030 shares will vest in successive equal quarterly installments through February 24, 2026, (b) 267,188 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest in successive equal quarterly installments through January 22, 2026 and (c) 120,000 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-quarter (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":778145,"source":{"system":"sec-edgar","filing":"0001415889-25-014693","document":"form4-05282025_040504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925014693/form4-05282025_040504.xml","form_type":"4"}},{"id":1166722,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-24T20:09:40.000Z","date":"2025-04-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":31866,"price":0.7763,"value":24737.5758,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on April 22, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on April 22, 2025 of $0.7763/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 57,196 shares resulting from the April 22, 2025 vesting installment of the Reporting Person's January 22, 2024 RSU grant, and the remaining 267,188 shares will vest in successive equal quarterly installments through January 22, 2026, (b) 20,039 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (c) 120,000 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-fourth (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":779937,"source":{"system":"sec-edgar","filing":"0001415889-25-011285","document":"form4-04242025_080437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925011285/form4-04242025_080437.xml","form_type":"4"}},{"id":1244025,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-26T22:31:20.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":560000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-quarter (1/4) of the shares subject to the option will vest and become exercisable on the first anniversary of the grant date, and the remainder of the shares will vest and become exercisable in 24 successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":560000,"derivative":{"exercise_price":0.9561,"expiration_date":"2035-02-24","underlying":"Common Stock","underlying_shares":560000},"source":{"system":"sec-edgar","filing":"0001415889-25-005705","document":"form4-02262025_100216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925005705/form4-02262025_100216.xml","form_type":"4"}},{"id":1244024,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-26T22:31:20.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock issuable upon settlement of a RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes: (a) 20,039 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026, (b) 356,250 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest in successive equal quarterly installments through January 22, 2026 and (c) 120,000 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-quarter (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":811803,"source":{"system":"sec-edgar","filing":"0001415889-25-005705","document":"form4-02262025_100216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925005705/form4-02262025_100216.xml","form_type":"4"}},{"id":1244023,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-26T22:31:20.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1375,"price":0.9561,"value":1314.6375,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares underlying the portion of an RSU grant that vested on February 25, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on February 25, 2025 of $0.9561/share, pursuant to the terms of the 2018 EIP. This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes:(a) 2,469 shares resulting from the February 25, 2025 final vesting installment of the Reporting Person's February 25, 2022 RSU grant, (b) 20,039 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (c) 356,250 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest in successive equal quarterly installments through January 22, 2026. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":691803,"source":{"system":"sec-edgar","filing":"0001415889-25-005705","document":"form4-02262025_100216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925005705/form4-02262025_100216.xml","form_type":"4"}},{"id":1244022,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-26T22:31:20.000Z","date":"2025-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1792,"price":1,"value":1792.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on February 24, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on February 24, 2025 of $1.00/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 3,218 shares resulting from the February 24, 2025 vesting installment of the Reporting Person's February 24, 2023 RSU grant, and the remaining 20,039 shares will vest in successive equal quarterly installments through February 24, 2026, (b) 3,844 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in one final quarterly installment on February 25, 2025, and (c) 356,250 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest in successive equal quarterly installments through January 22, 2026. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":693178,"source":{"system":"sec-edgar","filing":"0001415889-25-005705","document":"form4-02262025_100216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925005705/form4-02262025_100216.xml","form_type":"4"}},{"id":1252208,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-02-21T22:38:35.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":49575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2026."}],"balance_after":198219,"source":{"system":"sec-edgar","filing":"0001062993-25-003207","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299325003207/form4.xml","form_type":"4"}},{"id":1295886,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-24T21:05:13.000Z","date":"2025-01-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":129242,"price":1.15,"value":148628.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on January 22, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on January 22, 2025 of $1.15/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 227,008 shares resulting from the January 22, 2025 vesting installment of the Reporting Person's January 22, 2024 RSU grant, and the remaining 356,250 shares will vest in successive equal quarterly installments through January 22, 2026, (b) 3,844 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in one final installment on February 25, 2025 and (c) 25,049 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026.  The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":694970,"source":{"system":"sec-edgar","filing":"0001415889-25-002019","document":"form4-01242025_040104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925002019/form4-01242025_040104.xml","form_type":"4"}},{"id":1351546,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-11-26T21:08:12.000Z","date":"2024-11-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1371,"price":1.94,"value":2659.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares underlying the portion of an RSU grant that vested on November 25, 2024, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on November 25, 2024 of $1.94/share, pursuant to the terms of the 2018 EIP. This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes:(a) 2,473 shares resulting from the November 25, 2024 vesting installment of the Reporting Person's February 25, 2022 RSU grant, and the remaining 3,844 shares will vest in one final installment on February 25, 2025, (b) 25,049 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (c) 712,500 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter."}],"balance_after":824212,"source":{"system":"sec-edgar","filing":"0001415889-24-027703","document":"form4-11262024_091108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924027703/form4-11262024_091108.xml","form_type":"4"}},{"id":1351545,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-11-26T21:08:12.000Z","date":"2024-11-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1787,"price":1.88,"value":3359.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on November 24, 2024, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on November 22, 2024 of $1.88/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 3,223 shares resulting from the November 24, 2024 vesting installment of the Reporting Person's February 24, 2023 RSU grant, and the remaining 25,049 shares will vest in successive equal quarterly installments through February 24, 2026, (b) 7,688 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in successive equal quarterly installments through February 25, 2025, and (c) 712,500 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":825583,"source":{"system":"sec-edgar","filing":"0001415889-24-027703","document":"form4-11262024_091108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924027703/form4-11262024_091108.xml","form_type":"4"}},{"id":1422369,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-08-27T20:37:39.000Z","date":"2024-08-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1371,"price":0.86,"value":1179.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares underlying the portion of an RSU grant that vested on August 25, 2024, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on August 23, 2024 of $0.86/share, pursuant to the terms of the 2018 EIP. This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes:(a) 2,473 shares resulting from the August 25, 2024 vesting installment of the Reporting Person's February 25, 2022 RSU grant, and the remaining 7,688 shares will vest in successive equal quarterly installments through February 25, 2025, (b) 30,059 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (c) 712,500 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter."}],"balance_after":827370,"source":{"system":"sec-edgar","filing":"0001415889-24-022308","document":"form4-08272024_080835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924022308/form4-08272024_080835.xml","form_type":"4"}},{"id":1422368,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-08-27T20:37:39.000Z","date":"2024-08-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1787,"price":0.86,"value":1536.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on August 24, 2024, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on August 23, 2024 of $0.86/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 3,223 shares resulting from the August 24, 2024 vesting installment of the Reporting Person's February 24, 2023 RSU grant, and the remaining 30,059 shares will vest in successive equal quarterly installments through February 24, 2026, (b) 11,532 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in successive equal quarterly installments through February 25, 2025, and (c) 712,500 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":828741,"source":{"system":"sec-edgar","filing":"0001415889-24-022308","document":"form4-08272024_080835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924022308/form4-08272024_080835.xml","form_type":"4"}},{"id":1481270,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-13T20:42:13.000Z","date":"2024-06-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":892,"price":0.6077,"value":542.0684,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portions of RSU grants that vested on June 11, 2024, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on June 11, 2024 of $0.6077/share, pursuant to the terms of the 2018 EIP. This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 1,608 shares resulting from the June 11, 2024 final vesting installment of the Reporting Person's June 11, 2021 RSU grant, (b) 11,532 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in successive equal quarterly installments through February 25, 2025, (c) 35,069 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (d) 712,500 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":830528,"source":{"system":"sec-edgar","filing":"0001415889-24-016686","document":"form4-06132024_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924016686/form4-06132024_080609.xml","form_type":"4"}},{"id":1499536,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-29T20:57:40.000Z","date":"2024-05-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1371,"price":0.6,"value":822.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares underlying the portions of RSU grants that vested on May 25, 2024, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on May 24, 2024 of $0.60/share, pursuant to the terms of the 2018 EIP. This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes:(a) 2,472 shares resulting from the May 25, 2024 vesting installment of the Reporting Person's February 25, 2022 RSU grant, and the remaining 11,532 shares will vest in successive equal quarterly installments through February 25, 2025, (b) 2,500 shares subject to Reporting Person's June 11, 2021 RSU grant that will vest in one final installment on June 11, 2024, (c) 35,069 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (d) 712,500 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter."}],"balance_after":831420,"source":{"system":"sec-edgar","filing":"0001415889-24-014779","document":"form4-05292024_080536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924014779/form4-05292024_080536.xml","form_type":"4"}},{"id":1499535,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-29T20:57:40.000Z","date":"2024-05-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1787,"price":0.6,"value":1072.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portions of RSU grants that vested on May 24, 2024, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on May 24, 2024 of $0.60/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 3,222 shares resulting from the May 24, 2024 vesting installment of the Reporting Person's February 24, 2023 RSU grant, and the remaining 35,069 shares will vest in successive equal quarterly installments through February 24, 2026, (b) 15,375 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in successive equal quarterly installments through February 25, 2025, (c) 2,500 shares subject to Reporting Person's June 11, 2021 RSU grant that will vest in one final installment on June 11, 2024 and (d) 712,500 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":832791,"source":{"system":"sec-edgar","filing":"0001415889-24-014779","document":"form4-05292024_080536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924014779/form4-05292024_080536.xml","form_type":"4"}},{"id":1616972,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-27T22:12:44.000Z","date":"2024-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":3453,"price":1.13,"value":3901.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares underlying the portions of RSU grants that vested on February 25, 2024, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on February 23, 2024 of $1.13/share, pursuant to the terms of the 2018 EIP). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes: (a) 2,706 shares resulting from the February 25, 2024 final vesting installment of the Reporting Person's February 25, 2021 RSU grant, (b) 2,269 shares resulting from the February 25, 2024 vesting installment of the Reporting Person's February 25, 2022 RSU grant, and the remaining 15,375 shares will vest in successive equal quarterly installments through February 25, 2025, (c) 2,500 shares subject to Reporting Person's June 11, 2021 RSU grant that will vest in one final installment on June 11, 2024, (d) 40,078 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (e) 712,500 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter."}],"balance_after":834578,"source":{"system":"sec-edgar","filing":"0001415889-24-005548","document":"form4-02272024_100240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924005548/form4-02272024_100240.xml","form_type":"4"}},{"id":1616971,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-27T22:12:44.000Z","date":"2024-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":5474,"price":1.13,"value":6185.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portions of RSU grants that vested on February 24, 2024, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on February 23, 2024 of $1.13/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 7,886 shares resulting from the February 24, 2024 vesting installment of the Reporting Person's February 24, 2023 RSU grant, and the remaining 40,078 shares will vest in successive equal quarterly installments through February 24, 2026, (b) 4,584 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in one final installment on February 25, 2024, (c) 19,219 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in successive equal quarterly installments through February 25, 2025, (c) 2,500 shares subject to Reporting Person's June 11, 2021 RSU grant that will vest in one final installment on June 11, 2024 and (d) 712,500 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":838031,"source":{"system":"sec-edgar","filing":"0001415889-24-005548","document":"form4-02272024_100240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924005548/form4-02272024_100240.xml","form_type":"4"}},{"id":1621693,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-02-23T22:20:14.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":51020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2025."}],"balance_after":148644,"source":{"system":"sec-edgar","filing":"0001062993-24-004304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299324004304/form4.xml","form_type":"4"}},{"id":1672328,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-01-24T21:41:30.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":712500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through each such date and subject to acceleration in full in the event of a Change in Control (as defined in the 2018 EIP)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 4,584 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in one final installment on February 25, 2024, (b) 19,219 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in successive equal quarterly installments through February 25, 2025, (c) 53,438 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter and (d) 2,500 shares subject to Reporting Person's June 11, 2021 RSU grant that will vest in one final installment on June 11, 2024. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":843505,"source":{"system":"sec-edgar","filing":"0001415889-24-001756","document":"form4-01242024_090116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924001756/form4-01242024_090116.xml","form_type":"4"}},{"id":1728960,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-28T21:17:36.000Z","date":"2023-11-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1329,"price":0.3821,"value":507.8109,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on November 25, 2023, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on November 24, 2023 of $0.3821/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 2,515 shares resulting from the November 25, 2023 vesting installment of the Reporting Person's February 25, 2022 RSU grant, and the remaining 19,219 shares will vest in successive equal quarterly installments through February 25, 2025, (b)  4,584 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in one final installment on February 25, 2024 and (c) 53,438 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter and (d) 2,500 shares subject to Reporting Person's June 11, 2021 RSU grant that will vest in one final installment on June 11, 2024. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":131005,"source":{"system":"sec-edgar","filing":"0001209191-23-056778","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123056778/doc4.xml","form_type":"4"}},{"id":1794515,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-29T20:14:25.000Z","date":"2023-08-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1329,"price":0.77,"value":1023.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on August 25, 2023, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on August 25, 2023 of $0.77/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 2,515 shares resulting from the August 25, 2023 vesting installment of the Reporting Person's February 25, 2022 RSU grant, and the remaining 23,063 shares will vest in successive equal quarterly installments through February 25, 2025, (b)  4,584 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in one final installment on February 25, 2024 and (c) 53,438 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter and (d) 2,500 shares subject to Reporting Person's June 11, 2021 RSU grant that will vest in one final installment on June 11, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":132334,"source":{"system":"sec-edgar","filing":"0001209191-23-047585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123047585/doc4.xml","form_type":"4"}},{"id":1857771,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-13T20:55:50.000Z","date":"2023-06-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":864,"price":1.19,"value":1028.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on June 11, 2023, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on June 9, 2023 of $1.19/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 1,636 shares resulting from the June 11, 2023 vesting installment of the Reporting Person's June 11, 2021 RSU grant and 2,500 shares subject to such RSU grant that will vest in one final installment on June 11, 2024, (b) 26,907 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in successive equal quarterly installments through February 25, 2025, (c) 4,584 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in one final installment on February 25, 2024 and (d) 53,438 shares subject to the Reporting Person's February 24, 2023 RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 2,475 shares acquired on May 31, 2023 under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":133663,"source":{"system":"sec-edgar","filing":"0001209191-23-036788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123036788/doc4.xml","form_type":"4"}},{"id":1875340,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-30T20:41:23.000Z","date":"2023-05-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1328,"price":1.33,"value":1766.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on May 25, 2023, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on May 25, 2023 of $1.33/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 2,515 shares resulting from the May 25, 2023 vesting installment of the Reporting Person's February 25, 2022 RSU grant, and the remaining 26,907 shares will vest in successive equal quarterly installments through February 25, 2025, (b) 5,000 shares subject to the Reporting Person's June 11, 2022 RSU grant that will vest in two remaining installments of 2,500 shares on each of June 11, 2023 and 2024, (c) 4,584 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in one final installment on February 25, 2024 and (d) 53,438 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":132052,"source":{"system":"sec-edgar","filing":"0001209191-23-032906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123032906/doc4.xml","form_type":"4"}},{"id":1937270,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-28T21:04:30.000Z","date":"2023-03-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":345,"price":1.66,"value":572.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying the portion of a restricted stock unit (\"RSU\") grant that vested on March 25, 2023, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on March 24, 2023 of $1.66/share, pursuant to the terms of the Issuer's Amended and Restated Equity Incentive Plan (the \"2018 EIP\"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 655 shares resulting from the March 25, 2023 final vesting installment of the Reporting Person's March 25, 2020 RSU grant, (b) 4,584 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in one final installment on February 25, 2024, (c) 30,750 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in 8 successive equal quarterly installments after February 25, 2023, and (e) 5,000 shares subject to the Reporting Person's June 11, 2022 RSU grant that will vest in two remaining installments of 2,500 shares on each of June 11, 2023 and 2024. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":133380,"source":{"system":"sec-edgar","filing":"0001209191-23-021427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123021427/doc4.xml","form_type":"4"}},{"id":1970043,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T22:07:23.000Z","date":"2023-02-24","kind":"grant","acquired":true,"shares":249375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-quarter (1/4) of the shares subject to the option will vest and become exercisable on the first anniversary of the grant date, and the remainder of the shares will vest and become exercisable in 24 successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":249375,"derivative":{"exercise_price":2.66,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":249375},"source":{"system":"sec-edgar","filing":"0001209191-23-016390","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123016390/doc4.xml","form_type":"4"}},{"id":1970042,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-06T22:07:23.000Z","date":"2023-02-25","kind":"tax_withholding","acquired":false,"shares":7030,"price":2.66,"value":18699.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares underlying the portions of RSU grants that vested on February 25, 2023, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on February 24, 2023 of $2.66/share, pursuant to the terms of the 2018 EIP. This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 722 shares acquired on November 30, 2022 under the Issuer's 2020 Employee Stock Purchase Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes: (a) 3,599 shares resulting from the February 25, 2023 final vesting installment of the Reporting Person's February 25, 2020 RSU grant, (b) 2,999 shares resulting from the February 25, 2023 vesting installment of the Reporting Person's February 25, 2021 RSU grant and 4,584 shares subject to such RSU grant that will vest in one final installment on February 25, 2024, (c) 6,706 shares resulting from the February 25, 2023 vesting installment of the Reporting Person's February 25, 2022 RSU grant, and the remaining 30,750 shares will vest in 8 successive equal quarterly installments thereafter, (continued in footnote 5)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"(d) 1,000 shares subject to the Reporting Person's March 25, 2020 RSU grant that will vest in one final installment on March 25, 2023 and (e) 5,000 shares subject to the Reporting Person's June 11, 2022 RSU grant that will vest in two remaining installments of 2,500 shares on each of June 11, 2023 and 2024. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":133725,"source":{"system":"sec-edgar","filing":"0001209191-23-016390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123016390/doc4.xml","form_type":"4"}},{"id":1970041,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-06T22:07:23.000Z","date":"2023-02-24","kind":"grant","acquired":true,"shares":53438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through each such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 722 shares acquired on November 30, 2022 under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":140755,"source":{"system":"sec-edgar","filing":"0001209191-23-016390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123016390/doc4.xml","form_type":"4"}},{"id":1992275,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-24T22:47:51.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":65737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2024."}],"balance_after":97624,"source":{"system":"sec-edgar","filing":"0001062993-23-004886","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299323004886/form4.xml","form_type":"4"}},{"id":2031081,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-06T23:28:01.000Z","date":"2022-06-11","kind":"tax_withholding","acquired":false,"shares":864,"price":3.76,"value":3248.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on June 11, 2022 which were surrendered by the Reporting Person to the Issuer solely for mandatory tax withholding purposes using the Issuer's closing stock price on June 10, 2022 of $3.76/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\").  This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 1,658 shares resulting from the June 11, 2022 annual vesting installment of the Reporting Person's June 11, 2021 RSU grant and 5,000 shares subject to such grant that will vest in two remaining annual installments of 2,500 shares on each of June 11, 2023 and 2024, (b) 5,501 shares subject to the Reporting Person's February 25, 2020 RSU grant that will vest in one final annual installment on February 25, 2023, (c) 9,167 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in two remaining annual installments of 4,583 shares and 4,584 shares on February 25, 2023 and 2024, respectively, (continued in footnote 3)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(d) 41,000 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter, and (e) 1,000 shares subject to the Reporting Person's March 25, 2020 RSU grant that will vest in one final annual installment on March 25, 2023. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 687 shares acquired on May 31, 2022 under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":86595,"source":{"system":"sec-edgar","filing":"0001209191-23-007355","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123007355/doc4a.xml","form_type":"4/A","original_submission_date":"2022-06-14"}},{"id":2233205,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-06-14T20:37:06.000Z","date":"2022-06-11","kind":"tax_withholding","acquired":false,"shares":842,"price":3.76,"value":3165.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on June 11, 2022 which were surrendered by the Reporting Person to the Issuer for tax withholding using the Issuer's closing stock price on June 10, 2022 of $3.76/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 1,658 shares resulting from the June 11, 2022 annual vesting installment of the Reporting Person's June 11, 2021 RSU grant and 5,000 shares subject to such grant that will vest in two remaining annual installments of 2,500 shares on each of June 11, 2023 and 2024, (b) 5,501 shares subject to the Reporting Person's February 25, 2020 RSU grant that will vest in one final annual installment on February 25, 2023, (c) 9,167 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in two remaining annual installments of 4,583 shares and 4,584 shares on February 25, 2023 and 2024, respectively, (continued in footnote 3)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(d) 41,000 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter, and (e) 1,000 shares subject to the Reporting Person's March 25, 2020 RSU grant that will vest in one final annual installment on March 25, 2023. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 687 shares acquired on May 31, 2022 under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":86617,"source":{"system":"sec-edgar","filing":"0001209191-22-036702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122036702/doc4.xml","form_type":"4"}},{"id":2289893,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-04-27T21:08:53.000Z","date":"2022-04-25","kind":"tax_withholding","acquired":false,"shares":662,"price":4.83,"value":3197.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on April 25, 2022 which were surrendered by the Reporting Person to the Issuer for tax withholding using the Issuer's closing stock price on April 25, 2022 of $4.83/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 1,255 shares resulting from the April 25, 2022 final annual vesting installment of the Reporting Person's April 25, 2019 RSU grant, (b) 7,500 shares subject to the Reporting Person's June 11, 2021 RSU grant that will vest in three annual installments of 2,500 shares on each of June 11, 2022, 2023 and 2024, (c) 5,501 shares subject to the Reporting Person's February 25, 2020 RSU grant that will vest in one final annual installment on February 25, 2023, (d) 9,167 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in two remaining annual installments of 4,583 shares and 4,584 shares on February 25, 2023 and 2024, respectively, (continued in footnote 3)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(e) 41,000 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter, and (f) 1,000 shares subject to the Reporting Person's March 25, 2020 RSU grant that will vest in one final annual installment on March 25, 2023.  The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":86772,"source":{"system":"sec-edgar","filing":"0001209191-22-025809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122025809/doc4.xml","form_type":"4"}},{"id":2315831,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-03-29T20:41:30.000Z","date":"2022-03-25","kind":"tax_withholding","acquired":false,"shares":345,"price":5.75,"value":1983.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of a restricted stock unit (\"RSU\") grant that vested on March 25, 2022 which were surrendered by the Reporting Person to the Issuer for tax withholding using the Issuer's closing stock price on March 25, 2022 of $5.75/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 655 shares resulting from the March 25, 2022 vesting of Reporting Person's March 25, 2020 RSU grant and 1,000 shares subject to such RSU grant that will vest in one final annual installment on March 25, 2023, (b) 1,917 shares subject to Reporting Person's April 25, 2019 RSU grant that will vest in one final annual installment on April 25, 2022, (c) 7,500 shares subject to Reporting Person's June 11, 2021 RSU grant that will vest in three annual installments of 2,500 shares on each of June 11, 2022, 2023 and 2024, (d) 5,501 shares subject to Reporting Person's February 25, 2020 RSU grant that will vest in one final annual installment on February 25, 2023, (continued in footnote 3)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(e) 9,167 shares subject to Reporting Person's February 25, 2021 RSU grant that will vest in two remaining annual installments of 4,583 shares and 4,584 shares on February 25, 2023 and 2024, respectively, and (f) 41,000 shares subject to Reporting Person's February 25, 2022 RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter.  The vesting of all such grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":87434,"source":{"system":"sec-edgar","filing":"0001209191-22-021495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122021495/doc4.xml","form_type":"4"}},{"id":2366641,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-01T22:18:12.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":110700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-quarter (1/4) of the shares subject to the option will vest and become exercisable on the first anniversary of the grant date, and the remainder of the shares will vest and become exercisable in 24 successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":110700,"derivative":{"exercise_price":5.9,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":110700},"source":{"system":"sec-edgar","filing":"0001209191-22-014170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122014170/doc4.xml","form_type":"4"}},{"id":2366640,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-03-01T22:18:12.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock issuable upon settlement of an RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":87779,"source":{"system":"sec-edgar","filing":"0001209191-22-014170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122014170/doc4.xml","form_type":"4"}},{"id":2366639,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-03-01T22:18:12.000Z","date":"2022-02-25","kind":"tax_withholding","acquired":false,"shares":3474,"price":5.9,"value":20496.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portions of restricted stock unit (\"RSU\") grants that vested on February 25, 2022 which were surrendered by the Reporting Person to the Issuer for tax withholding using the Issuer's closing stock price on February 25, 2022 of $5.90/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 3,609 shares resulting from the February 25, 2022 vesting of the Reporting Person's February 25, 2020 RSU grant and 5,501 shares subject to such RSU grant that will vest in one final annual installment on February 25, 2023, (b) 2,999 shares resulting from the February 25, 2022 vesting of the Reporting Person's February 25, 2021 RSU grant and 9,167 shares subject to such RSU grant that will vest in two remaining annual installments of 4,583 shares and 4,584 shares on February 25, 2023 and 2024, respectively, (c) 2,000 shares subject to Reporting Person's March 25, 2020 RSU grant that will vest in two remaining annual installments of 1,000 shares on each of March 25, 2022 and 2023, (d) 1,917 shares subject to Reporting Person's April 25, 2019 RSU grant that will vest in one final annual installment on April 25, 2022 and (see footnote 3)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(e) 7,500 shares subject to Reporting Person's June 11, 2021 RSU grant that will vest in three annual installments of 2,500 shares on each of June 11, 2022, 2023 and 2024. The vesting of all such grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 426 shares acquired on October 29, 2021 under the Issuer's 2010 Employee Stock Purchase Plan."}],"balance_after":46779,"source":{"system":"sec-edgar","filing":"0001209191-22-014170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122014170/doc4.xml","form_type":"4"}},{"id":2387364,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-02-18T00:03:18.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":20547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2023."}],"balance_after":31887,"source":{"system":"sec-edgar","filing":"0001062993-22-004810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299322004810/form4.xml","form_type":"4"}},{"id":2497013,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-24T00:15:03.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":11340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over three years beginning November 19, 2021."}],"balance_after":11340,"source":{"system":"sec-edgar","filing":"0001062993-21-011496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299321011496/form4.xml","form_type":"4"}},{"id":2670774,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO, PFO and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T23:17:33.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of Continuous Service, as defined in the 2018 EIP, as amended, by the Reporting Person measured from the June 11, 2021 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through each such vesting date, and subject to acceleration as provided in the 2018 EIP, as amended."}],"balance_after":15000,"derivative":{"exercise_price":11.76,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-040405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121040405/doc4.xml","form_type":"4"}},{"id":2670773,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO, PFO and PAO"}}],"security":"Common Stock","published_at":"2021-06-14T23:17:33.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 7,500 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on June 11, 2021 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's Continuous Service as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 2,000 shares acquired by the Reporting Person on April 30, 2021 under the Issuer's 2010 Employee Stock Purchase Plan, as amended; and (b) 199 shares acquired by the Reporting Person on May 28, 2021 under the Issuer's 2020 Employee Stock Purchase Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount also includes (a) 1,917 shares subject to the Reporting Person's April 25, 2019 RSU grant that will vest on April 25, 2022; (b) 11,000 shares subject to the Reporting Person's February 25, 2020 RSU grant that will vest in two remaining annual installments of 5,499 shares and 5,501 shares on February 25, 2022 and 2023 respectively; (c) 13,750 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date; and (continued in footnote 4)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"(d) 2,000 shares subject to the Reporting Person's March 25, 2020 RSU grant that will vest in two remaining annual installments of 1,000 shares each shares on March 25, 2022 and 2023, respectively. The vesting of all such RSUs is subject to the Reporting Person's continued service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended."}],"balance_after":49827,"source":{"system":"sec-edgar","filing":"0001209191-21-040405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121040405/doc4.xml","form_type":"4"}},{"id":2738867,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, PFO and PAO"}}],"security":"Common Stock","published_at":"2021-04-28T00:49:01.000Z","date":"2021-04-25","kind":"tax_withholding","acquired":false,"shares":662,"price":11.71,"value":7752.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of restricted stock unit (\"RSU\") grant that vested on April 25, 2021 which were surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on April 23, 2021 of $11.71/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 1,254 shares resulting from the April 25, 2021 vesting of the Reporting Person's April 25, 2019 RSU grant and 1,917 shares subject to such RSU grant that will vest on April 25, 2022; (b) 11,000 shares subject to the Reporting Person's February 25, 2020 RSU grant that will vest in two remaining annual installments of 5,499 shares and 5,501 shares on February 25, 2022 and 2023 respectively; (c) 13,750 shares subject to the Reporting Person's February 25, 2021 grant that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date; and (continued in footnote 3)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(d) 2,000 shares subject to the Reporting Person's March 25, 2020 RSU grant that will vest in two remaining annual installments of 1,000 shares each shares on March 25, 2022 and 2023, respectively.  The vesting of all such RSUs is subject to the Reporting Person's continued service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended."}],"balance_after":40128,"source":{"system":"sec-edgar","filing":"0001209191-21-028744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121028744/doc4.xml","form_type":"4"}},{"id":2738866,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, PFO and PAO"}}],"security":"Common Stock","published_at":"2021-04-28T00:46:52.000Z","date":"2021-03-25","kind":"tax_withholding","acquired":false,"shares":345,"price":12.27,"value":4233.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of restricted stock unit (\"RSU\") grant that vested on March 25, 2021 which were surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on March 25, 2021 of $12.27/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 655 shares resulting from the March 25, 2021 vesting of the Reporting Person's March 25, 2020 RSU grant and 2,000 shares subject to such RSU grant that will vest in two remaining annual installments of 1,000 shares and 1,000 shares on March 25, 2022 and 2023 respectively; (b) 3,833 shares subject to the Reporting Person's April 25, 2019 RSU grant that will vest in two remaining annual installments of 1,916 shares and 1,917 shares on April 25, 2021 and 2022 respectively; (c) 11,000 shares subject to the Reporting Person's February 25, 2020 RSU grant that will vest in two remaining annual installments of 5,499 shares and 5,501 shares on February 25, 2022 and 2023 respectively; and (continued in Footnote 3)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(d) 13,750 shares subject to the Reporting Person's February 25, 2021 grant that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date.  The vesting of all such RSUs is subject to the Reporting Person's continued service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This Form 4/A is being filed solely to correct the stated amount included in Footnote 3 on the Form 4 filed on behalf of the Reporting Person on March 29, 2021 to be 13,750 shares subject to RSUs vesting which was erroneously reported to be 44,000 shares in such Footnote 3."}],"balance_after":40790,"source":{"system":"sec-edgar","filing":"0001209191-21-028742","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121028742/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-29"}},{"id":2738865,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, PFO and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-28T00:45:56.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of Continuous Service, as defined in the 2018 EIP, as amended, by the Reporting Person measured from the February 25, 2021 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through each such vesting date, and subject to acceleration as provided in the 2018 EIP, as amended."}],"balance_after":27500,"derivative":{"exercise_price":11.19,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-21-028741","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121028741/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-01"}},{"id":2738864,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, PFO and PAO"}}],"security":"Common Stock","published_at":"2021-04-28T00:45:56.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents 13,750 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on February 25, 2021 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended."},{"field":"shares","element":"transactionShares","label":"F5","text":"This Form 4/A is being filed solely to correct the stated amount included in Footnote 4 on the Form 4 filed on behalf of the Reporting Person on March 1, 2021 to be 13,750 shares subject to RSUs vesting which was erroneously reported to be 44,000 shares in such Footnote 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 2,000 shares of common stock and 645 shares of common stock acquired by the Reporting Person on April 30, 2020 and October 30, 2020 respectively under the Issuer's 2010 Employee Stock Purchase Plan, as amended; (b) 3,637 shares resulting from the February 25, 2021 vesting of the Reporting Person's February 25, 2020 RSU grant and 11,000 shares subject to such RSU grant that will vest in two remaining annual installments of 5,499 shares and 5,501 shares on February 25, 2022 and 2023 respectively;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(c) 3,833 shares subject to the Reporting Person's April 25, 2019 grant that will vest in two remaining annual installments of 1,916 shares and 1,917 shares on April 25, 2021 and 2022 respectively; and (d) 3,000 shares subject to the Reporting Person's March 25, 2020 RSU grant that will vest in three annual installments of 1,000 shares on each of March 25, 2021, 2022 and 2023 respectively.  The vesting of all such RSUs is subject to the Reporting Person's continued service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended"}],"balance_after":41135,"source":{"system":"sec-edgar","filing":"0001209191-21-028741","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121028741/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-01"}},{"id":2738863,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, PFO and PAO"}}],"security":"Common Stock","published_at":"2021-04-28T00:45:56.000Z","date":"2021-02-25","kind":"tax_withholding","acquired":false,"shares":1863,"price":11.19,"value":20846.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of restricted stock unit (\"RSU\") grant that vested on February 25, 2021 which were surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on February 25, 2021 of $11.19/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 2,000 shares of common stock and 645 shares of common stock acquired by the Reporting Person on April 30, 2020 and October 30, 2020 respectively under the Issuer's 2010 Employee Stock Purchase Plan, as amended; (b) 3,637 shares resulting from the February 25, 2021 vesting of the Reporting Person's February 25, 2020 RSU grant and 11,000 shares subject to such RSU grant that will vest in two remaining annual installments of 5,499 shares and 5,501 shares on February 25, 2022 and 2023 respectively;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(c) 3,833 shares subject to the Reporting Person's April 25, 2019 grant that will vest in two remaining annual installments of 1,916 shares and 1,917 shares on April 25, 2021 and 2022 respectively; and (d) 3,000 shares subject to the Reporting Person's March 25, 2020 RSU grant that will vest in three annual installments of 1,000 shares on each of March 25, 2021, 2022 and 2023 respectively.  The vesting of all such RSUs is subject to the Reporting Person's continued service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended"}],"balance_after":27385,"source":{"system":"sec-edgar","filing":"0001209191-21-028741","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121028741/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-01"}},{"id":2769785,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, PFO and PAO"}}],"security":"Common Stock","published_at":"2021-03-29T23:11:35.000Z","date":"2021-03-25","kind":"tax_withholding","acquired":false,"shares":345,"price":12.27,"value":4233.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of restricted stock unit (\"RSU\") grant that vested on March 25, 2021 which were surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on March 25, 2021 of $12.27/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 655 shares resulting from the March 25, 2021 vesting of the Reporting Person's March 25, 2020 RSU grant and 2,000 shares subject to such RSU grant that will vest in two remaining annual installments of 1,000 shares and 1,000 shares on March 25, 2022 and 2023 respectively; (b) 3,833 shares subject to the Reporting Person's April 25, 2019 RSU grant that will vest in two remaining annual installments of 1,916 shares and 1,917 shares on April 25, 2021 and 2022 respectively; (c) 11,000 shares subject to the Reporting Person's February 25, 2020 RSU grant that will vest in two remaining annual installments of 5,499 shares and 5,501 shares on February 25, 2022 and 2023 respectively; and"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(d) 44,000 shares subject to the Reporting Person's February 25, 2021 grant that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date.  The vesting of all such RSUs is subject to the Reporting Person's continued service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended."}],"balance_after":40790,"source":{"system":"sec-edgar","filing":"0001209191-21-023480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121023480/doc4.xml","form_type":"4"}},{"id":2827663,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Principal Acct. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-02T02:12:45.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of Continuous Service, as defined in the 2018 EIP, as amended, by the Reporting Person measured from the February 25, 2021 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through each such vesting date, and subject to acceleration as provided in the 2018 EIP, as amended."}],"balance_after":27500,"derivative":{"exercise_price":11.19,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-21-015525","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121015525/doc4.xml","form_type":"4"}},{"id":2827662,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Principal Acct. Officer"}}],"security":"Common Stock","published_at":"2021-03-02T02:12:45.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents 44,000 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on February 25, 2021 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended."}],"balance_after":41135,"source":{"system":"sec-edgar","filing":"0001209191-21-015525","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121015525/doc4.xml","form_type":"4"}},{"id":2827661,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Principal Acct. Officer"}}],"security":"Common Stock","published_at":"2021-03-02T02:12:45.000Z","date":"2021-02-25","kind":"tax_withholding","acquired":false,"shares":1863,"price":11.19,"value":20846.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of restricted stock unit (\"RSU\") grant that vested on February 25, 2021 which were surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on February 25, 2021 of $11.19/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (a) 2,000 shares of common stock and 645 shares of common stock acquired by the Reporting Person on April 30, 2020 and October 30, 2020 respectively under the Issuer's 2010 Employee Stock Purchase Plan, as amended; (b) 3,637 shares resulting from the February 25, 2021 vesting of the Reporting Person's February 25, 2020 RSU grant and 11,000 shares subject to such RSU grant that will vest in two remaining annual installments of 5,499 shares and 5,501 shares on February 25, 2022 and 2023 respectively;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(c) 3,833 shares subject to the Reporting Person's April 25, 2019 grant that will vest in two remaining annual installments of 1,916 shares and 1,917 shares on April 25, 2021 and 2022 respectively; and (d) 3,000 shares subject to the Reporting Person's March 25, 2020 RSU grant that will vest in three annual installments of 1,000 shares on each of March 25, 2021, 2022 and 2023 respectively.  The vesting of all such RSUs is subject to the Reporting Person's continued service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended"}],"balance_after":27385,"source":{"system":"sec-edgar","filing":"0001209191-21-015525","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121015525/doc4.xml","form_type":"4"}},{"id":3168507,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Principal Acct. Officer"}}],"security":"Common Stock","published_at":"2020-04-28T22:59:29.000Z","date":"2020-04-25","kind":"tax_withholding","acquired":false,"shares":647,"price":8.32,"value":5383.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of the restricted stock unit grant that vested on April 25, 2020 surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on April 24, 2020 of $8.32/share, pursuant to the terms of the Issuer's 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: 1,270 shares resulting from the April 25, 2020 vesting of Reporting Person's April 25, 2019 restricted stock unit (\"RSU\") grant; 3,833 shares subject to such RSU grant that will vest in two remaining annual installments on April 25, 2021 and 2022, resulting in such RSU grant being vested in full on the third (3rd) anniversary of the grant date; 16,500 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on February 25, 2020; and 3,000 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on March 25, 2020. All such RSUs vest with respect to 1/3rd of the shares in each respective RSU grant in three equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's continued service with the Issuer through such dates."}],"balance_after":26603,"source":{"system":"sec-edgar","filing":"0001209191-20-026045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120026045/doc4.xml","form_type":"4"}},{"id":3194647,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Principal Acct. Officer"}}],"security":"Common Stock","published_at":"2020-03-26T23:18:27.000Z","date":"2020-03-25","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 3,000 shares subject to restricted stock units granted on March 25, 2020 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,750 shares of common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person on April 25, 2019 and 16,500 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on February 25, 2020. All such RSUs will vest with respect to 1/3rd of the shares in three equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's continued service with the Issuer through such dates."}],"balance_after":27250,"source":{"system":"sec-edgar","filing":"0001209191-20-021346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120021346/doc4.xml","form_type":"4"}},{"id":3247071,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Principal Acct. Officer"}}],"security":"Stock Option (Right-to-Buy)","published_at":"2020-02-27T00:50:27.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the February 25, 2020 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":33000,"derivative":{"exercise_price":6.8,"expiration_date":"2030-02-02","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001209191-20-013239","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120013239/doc4a.xml","form_type":"4/A","original_submission_date":"2020-02-26"}},{"id":3247070,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Principal Acct. Officer"}}],"security":"Common Stock","published_at":"2020-02-27T00:50:27.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 16,500 shares subject to restricted stock units granted on February 25, 2020 that will vest in three (3) equal annual installments on\neach anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting\nPerson's continued service with the Issuer through such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,000 shares acquired by the Reporting Person on October 31, 2019 under the Issuer's 2010 Employee Stock Purchase Plan, as amended."}],"balance_after":24250,"source":{"system":"sec-edgar","filing":"0001209191-20-013239","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120013239/doc4a.xml","form_type":"4/A","original_submission_date":"2020-02-26"}},{"id":3247069,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Principal Acct. Officer"}}],"security":"Stock Option (Right-to-Buy)","published_at":"2020-02-27T00:34:46.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the February 25, 2020 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":33000,"derivative":{"exercise_price":6.8,"expiration_date":"2030-02-02","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001209191-20-013233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120013233/doc4.xml","form_type":"4"}},{"id":3247068,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Principal Acct. Officer"}}],"security":"Common Stock","published_at":"2020-02-27T00:34:46.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 16,500 shares subject to restricted stock units granted on February 25, 2020 that will vest in three (3) equal annual installments on\neach anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting\nPerson's continued service with the Issuer through such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,000 shares acquired by the Reporting Person on October 31, 2019 under the Issuer's 2010 Employee Stock Purchase Plan, as amended."}],"balance_after":22250,"source":{"system":"sec-edgar","filing":"0001209191-20-013233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120013233/doc4.xml","form_type":"4"}}]}